Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Hawkey, CJ' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 292 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Hawkey, CJ
      COX-1 and COX-2 inhibitors

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    2. Hawkey, CJ
      Journals should see original protocols for clinical trials

      BRITISH MEDICAL JOURNAL
    3. Seager, JM; Hawkey, CJ
      ABC of the upper gastrointestinal tract - Indigestion and non-steroidal anti-inflammatory drugs

      BRITISH MEDICAL JOURNAL
    4. Hawkey, CJ
      Quality of life in reflux disease: what does it mean?

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    5. Hawkey, CJ
      Should symptom control be the main determinant of duration of initial therapy?

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    6. Hawkey, CJ
      Daily or 'on-demand' therapy for patients with Los Angeles grade A or B oesophagitis?

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    7. Hawkey, CJ
      Gastrointestinal safety of COX-2 specific inhibitors

      GASTROENTEROLOGY CLINICS OF NORTH AMERICA
    8. Hawkey, CJ
      NSAIDs and COX-2 inhibitors: what can we learn from large outcomes trials?The gastroenterologist's perspective

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    9. Longstreth, GF; Hawkey, CJ; Mayer, EA; Jones, RH; Naesdal, J; Wilson, IK; Peacock, RA; Wiklund, IK
      Characteristics of patients with irritable bowel syndrome recruited from three sources: implications for clinical trials

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    10. Hawkey, CJ; Laine, L; Harper, SE; Quan, HUI; Bolognese, JA; Mortensen, E
      Influence of risk factors on endoscopic and clinical ulcers in patients taking rofecoxib or ibuprofen in two randomized controlled trials

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    11. Hawkey, CJ; Jackson, L; Harper, SE; Simon, TJ; Mortensen, E; Lines, CR
      The gastrointestinal safety profile of rofecoxib, a highly selective inhibitor of cyclooxygenase-2, in humans

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    12. Hawkey, CJ; Emery, P; Moore, A
      Selective cyclo-oxygenase inhibitors - Authors' reply

      LANCET
    13. Emery, P; Hawkey, CJ; Moore, A
      Prescribing in the UK

      LANCET
    14. Kubba, AK; Selby, NM; Hawkey, CJ
      Update in the pharmacological management of peptic ulcer haemorrhage

      SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
    15. Hawkey, GM; Cole, AT; McIntyre, AS; Long, RG; Hawkey, CJ
      Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points

      GUT
    16. Hawkey, CJ
      Discussion on rofecoxib, a COX-2 inhibitor, does not inhibit human gastricmucosal prostaglandin production - Reply

      GASTROENTEROLOGY
    17. Wight, NJ; Gottesdiener, K; Garlick, NM; Atherton, CT; Novak, S; Gertz, BJ; Calder, NA; Cote, J; Wong, P; Dallob, A; Hawkey, CJ
      Rofecoxib, a COX-2 inhibitor, does not inhibit human gastric mucosal prostaglandin production

      GASTROENTEROLOGY
    18. Stack, WA; Richardson, PD; Logan, RPH; Mahida, YR; Hawkey, CJ
      Nocardia asteroides lung abscess in acute ulcerative colitis treated with cyclosporine

      AMERICAN JOURNAL OF GASTROENTEROLOGY
    19. Hawkey, CJ
      Management of gastroduodenal ulcers caused by non-steroidal anti-inflammatory drugs

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    20. Hawkey, CJ
      Outcomes studies of drug induced ulcer complications: do we need them and how should they be done?

      BRITISH MEDICAL JOURNAL
    21. Hawkey, CJ
      What consideration should be given to Helicobacter pylori in treating nonsteroidal anti-inflammatory drug ulcers?

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    22. Yeomans, ND; Garas, G; Hawkey, CJ
      The nonsteroidal anti-inflammatory drugs controversy

      GASTROENTEROLOGY CLINICS OF NORTH AMERICA
    23. Selby, NM; Kubba, AK; Hawkey, CJ
      Acid suppression in peptic ulcer haemorrhage: a 'meta-analysis'

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    24. Donnelly, MT; Goddard, AF; Filipowicz, B; Morant, SV; Shield, MJ; Hawkey, CJ
      Low-dose misoprostol for the prevention of low-dose aspirin-induced gastroduodenal injury

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    25. Donnelly, MT; Richardson, P; Hawkey, CJ; Courtauld, E; Stack, WA
      Dose-dependent effects of ketoprofen on the human gastric mucosa in comparison with ibuprofen

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    26. Hawkey, CJ
      Reply - On dissonances, Helicobacter pylori and NSAIDs

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    27. Hawkey, CJ; Cullen, DJE; Pearson, G; Holmes, S; Doherty, M; Wilson, JV; Garrud, P; Garner, S; Maynard, A; Logan, RFA
      Pharmacoepidemiology of non-steroidal anti-inflammatory drug use in Nottingham general practices

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    28. Hawkey, CJ; Cullen, DJE; Pearson, G; Holmes, S; Doherty, M; Wilson, JV; Garrud, P; Garner, S; Maynard, A; Logan, RFA
      Ibuprofen versus other non-steroidal anti-inflammatory drugs: use in general practice and patient perception

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    29. Seager, JM; Cullen, DJE; Pearson, G; Holmes, S; Doherty, M; Wilson, JV; Garrud, P; Garner, S; Maynard, A; Logan, RFA; Hawkey, CJ
      Ibuprofen versus other non-steroidal anti-inflammatory drugs: use in general practice and patient perception (vol 14, pg 187, 2000)

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    30. Cullen, DJE; Seager, JM; Holmes, S; Doherty, M; Wilson, JV; Garrud, P; Garner, S; Maynard, A; Logan, RFA; Hawkey, CJ
      Pharmacoepidemiology of non-steroidal anti-inflammatory drug use in Nottingham general practices (vol 14, pg 177, 2000)

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    31. Pathmakanthan, S; Hawkey, CJ
      A lay doctor's guide to the inflammatory process in the gastrointestinal tract

      POSTGRADUATE MEDICAL JOURNAL
    32. Bombardier, C; Laine, L; Reicin, A; Shapiro, D; Burgos-Vargas, R; Davis, B; Day, R; Ferraz, MB; Hawkey, CJ; Hochberg, MC; Kvien, TK; Schnitzer, TJ; Weaver, A
      Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen inpatients with rheumatoid arthritis.

      NEW ENGLAND JOURNAL OF MEDICINE
    33. Jenkins, D; Seth, R; Kummer, JA; Scott, BB; Hawkey, CJ; Robins, RA
      Differential levels of granzyme B, regulatory cytokines, and apoptosis in Crohn's disease and ulcerative colitis at first presentation

      JOURNAL OF PATHOLOGY
    34. Jackson, LM; Wu, KC; Mahida, YR; Jenkins, D; Hawkey, CJ
      Cyclooxygenase (COX) 1 and 2 in normal, inflamed, and ulcerated human gastric mucosa

      GUT
    35. Hawkey, CJ; Snowden, JA; Lobo, A; Beglinger, C; Tyndall, A
      Stem cell transplantation for inflammatory bowel disease: practical and ethical issues

      GUT
    36. Hawkey, CJ
      Risk of ulcer bleeding in patients infected with Helicobacter pylori taking non-steroidal anti-inflammatory drugs

      GUT
    37. Hawkey, CJ
      Nonsteroidal anti-inflammatory drug gastropathy

      GASTROENTEROLOGY
    38. Jackson, LM; Hawkey, CJ
      COX-2 selective nonsteroidal anti-inflammatory drugs - Do they really offer any advantages?

      DRUGS
    39. Brooks, P; Emery, P; Evans, JF; Fenner, H; Hawkey, CJ; Patrono, C; Smolen, J; Breeveld, F; Day, R; Dougados, M; Ehrich, EW; Gijon-Banos, J; Kvien, TK; Van Rijswijk, MH; Warner, T; Zeidler, H
      Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2

      RHEUMATOLOGY
    40. Hawkey, CJ
      Omeprazole and bleeding peptic ulcer, or "how case-control studies can tell you what you suspected all along"

      EPIDEMIOLOGY
    41. Hawkey, CJ
      Is Helicobacter pylori eradication useful in patients taking NSAIDs?

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    42. Hawkey, CJ; Moayyedi, P; Dent, J; Axon, A; Malfertheiner, P; Forman, D
      Should we go further and screen and treat? Discussion III

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    43. Hawkey, CJ; Yeomans, ND
      Untitled

      CANADIAN JOURNAL OF GASTROENTEROLOGY
    44. Hawkey, CJ
      What do we do about Helicobacter pylori?

      CANADIAN JOURNAL OF GASTROENTEROLOGY
    45. Beltinger, J; McKaig, BC; Makh, S; Stack, WA; Hawkey, CJ; Mahida, YR
      Human colonic subepithelial myofibroblasts modulate transepithelial resistance and secretory response

      AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
    46. Beltinger, J; Hawkey, CJ; Stack, WA
      TGF-alpha reduces bradykinin-stimulated ion transport and prostaglandin release in human colonic epithelial cells

      AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
    47. Atherton, JC; Sharp, PM; Cover, TL; Gonzalez-Valencia, G; Peek, RM; Thompson, SA; Hawkey, CJ; Blaser, MJ
      Vacuolating cytotoxin (vacA) alleles of Helicobacter pylori comprise two geographically widespread types, m1 and m2, and have evolved through limitedrecombination

      CURRENT MICROBIOLOGY
    48. Hawkey, CJ
      Personal review: Helicobacter pylori, NSAIDs and cognitive dissonance

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    49. Duggan, AE; Stack, W; Hull, M; Filipowicz, B; Knifton, A; Crome, R; Weber, C; Bishop, A; Polak, J; Hawkey, CJ
      Protection against aspirin-induced human gastric mucosal injury by bosentan, a new endothelin-1 receptor antagonist

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    50. Cole, AT; Hudson, N; Liew, LCW; Murray, FE; Hawkey, CJ; Heptinstall, S
      Protection of human gastric mucosa against aspirin - enteric coating or dose reduction?

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    51. McKaig, BC; Makh, SS; Hawkey, CJ; Podolsky, DK; Mahida, YR
      Normal human colonic subepithelial myofibroblasts enhance epithelial migration (restitution) via TGF-beta 3

      AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
    52. Hawkey, CJ
      COX-2 inhibitors - Reply

      LANCET
    53. Hawkey, CJ
      COX-2 inhibitors

      LANCET
    54. Atherton, JC; Cover, TL; Twells, RJ; Morales, MR; Hawkey, CJ; Blaser, MJ
      Simple and accurate PCR-based system for typing vacuolating cytotoxin alleles of Helicobacter pylori

      JOURNAL OF CLINICAL MICROBIOLOGY
    55. Letley, DP; Lastovica, A; Louw, JA; Hawkey, CJ; Atherton, JC
      Allelic diversity of the Helicobacter pylori vacuolating cytotoxin gene inSouth Africa: Rarity of the vacA s1a genotype and natural occurrence of ans2/m1 allele

      JOURNAL OF CLINICAL MICROBIOLOGY
    56. Hawkey, CJ
      Ulcerative colitis: How to handle the acute situation

      DRUGS OF TODAY
    57. Hull, MA; Thomson, JL; Hawkey, CJ
      Expression of cyclooxygenase 1 and 2 by human gastric endothelial cells

      GUT
    58. Wu, KC; Jackson, LM; Galvin, AM; Gray, T; Hawkey, CJ; Mahida, YR
      Phenotypic and functional characterisation of myofibroblasts, macrophages,and lymphocytes migrating out of the human gastric lamina propria following the loss of epithelial cells

      GUT
    59. Taha, AS; Dahill, S; Morran, C; Hudson, N; Hawkey, CJ; Lee, FD; Sturrock, RD; Russell, RI
      Neutrophils, Helicobacter pylori, and nonsteroidal anti-inflammatory drug ulcers

      GASTROENTEROLOGY
    60. Damstrup, L; Kuwada, SK; Dempsey, PJ; Brown, CL; Hawkey, CJ; Poulsen, HS; Wiley, HS; Coffey, RJ
      Amphiregulin acts as an autocrine growth factor in two human polarizing colon cancer lines that exhibit domain selective EGF receptor mitogenesis

      BRITISH JOURNAL OF CANCER
    61. DUGGAN AE; TOLLEY K; HAWKEY CJ; LOGAN RFA
      VARYING EFFICACY OF HELICOBACTER-PYLORI ERADICATION REGIMENS - COST-EFFECTIVENESS STUDY USING A DECISION-ANALYSIS MODEL

      BMJ. British medical journal
    62. DUGGAN AE; HARDY E; HAWKEY CJ
      EVALUATION OF A NEW NEAR PATIENT TEST FOR THE DETECTION OF HELICOBACTER-PYLORI

      European journal of gastroenterology & hepatology
    63. HAWKEY CJ
      NON STEROIDAL ANTIINFLAMMATORY DRUGS - MINIMIZING THE HARM, MAXIMIZING THE BENEFIT - COMMENTARY

      The Italian Journal of Gastroenterology
    64. CULLEN D; BARDHAN KD; EISNER M; KOGUT DG; PEACOCK RA; THOMSON JM; HAWKEY CJ
      PRIMARY GASTRODUODENAL PROPHYLAXIS WITH OMEPRAZOLE FOR NONSTEROIDAL ANTIINFLAMMATORY DRUG-USERS

      Alimentary pharmacology & therapeutics
    65. STACK WA; LONG RG; HAWKEY CJ
      SHORT-TERM AND LONG-TERM OUTCOME OF PATIENTS TREATED WITH CYCLOSPORINE FOR SEVERE ACUTE ULCERATIVE-COLITIS

      Alimentary pharmacology & therapeutics
    66. HAWKEY CJ
      RANDOMIZED CONTROLLED TRIAL OF HELICOBACTER-PYLORI ERADICATION IN PATIENTS ON NONSTEROIDAL ANTIINFLAMMATORY DRUGS - HELP NSAIDS STUDY (VOL 352, PG 1016, 1998)

      Lancet
    67. HAWKEY CJ; TULASSAY Z; SZCZEPANSKI L; VANRENSBURG CJ; FILIPOWICZSOSNOWSKA A; LANAS A; WASON CM; PEACOCK RA; GILLON KRW
      RANDOMIZED CONTROLLED TRIAL OF HELICOBACTER-PYLORI ERADICATION IN PATIENTS ON NONSTEROIDAL ANTIINFLAMMATORY DRUGS - HELP NSAIDS STUDY

      Lancet
    68. HAWKEY CJ; YEOMANS ND; GILLON K
      HELICOBACTER-PYLORI, NSAIDS, AND PEPTIC-ULCERS

      Lancet
    69. Hawkey, CJ
      Helicobacter pylori eradication in long-term users of non-steroidal anti-inflammatory drugs - Reply

      LANCET
    70. HAWKEY CJ; YEOMANS ND
      THERAPIES FOR ULCERS ASSOCIATED WITH NONSTEROIDAL ANTIINFLAMMATORY DRUGS - REPLY

      The New England journal of medicine
    71. HAWKEY CJ; STACK WA
      CHIMERIC MONOCLONAL-ANTIBODY CA2 TO TUMOR-NECROSIS-FACTOR-ALPHA FOR CROHNS-DISEASE

      The New England journal of medicine
    72. YEOMANS ND; TULASSAY Z; JUHASZ L; RACZ I; HOWARD JM; VANRENSBURG CJ; SWANNELL AJ; HAWKEY CJ
      A COMPARISON OF OMEPRAZOLE WITH RANITIDINE FOR ULCERS ASSOCIATED WITHNONSTEROIDAL ANTIINFLAMMATORY DRUGS

      The New England journal of medicine
    73. HAWKEY CJ; KARRASCH JA; SZCZEPANSKI L; WALKER DG; BARKUN A; SWANNELL AJ; YEOMANS ND
      OMEPRAZOLE COMPARED WITH MISOPROSTOL FOR ULCERS ASSOCIATED WITH NONSTEROIDAL ANTIINFLAMMATORY DRUGS

      The New England journal of medicine
    74. LOGAN RPH; ROBINS A; TURNER GA; COCKAYNE A; BORRIELLO SP; HAWKEY CJ
      A NOVEL FLOW CYTOMETRIC ASSAY FOR QUANTITATING ADHERENCE OF HELICOBACTER-PYLORI TO GASTRIC EPITHELIAL-CELLS

      Journal of immunological methods
    75. HAWKEY CJ; KARRASCH JA; SZCZEPANSKI L
      OMEPRAZOLE LED TO GREATER REMISSION RATE THAN MISOPROSTOL FOR ULCERS ASSOCIATED WITH NONSTEROIDAL ANTIINFLAMMATORY DRUGS

      Gut
    76. HULL MA; BROUGH JL; POWE DG; CARTER GI; JENKINS D; HAWKEY CJ
      EXPRESSION OF BASIC FIBROBLAST-GROWTH-FACTOR IN INTACT AND ULCERATED HUMAN GASTRIC-MUCOSA

      Gut
    77. HAWKEY CJ
      NAPROXEN SODIUM DID NOT LEAD TO SUBSTANTIALLY MORE UPPER GASTROINTESTINAL-TRACT BLEEDING THAN IBUPROFEN DURING SHORT-TERM USE AS AN ANALGESIC - COMMENTARY

      Gut
    78. MCALINDON ME; HAWKEY CJ; MAHIDA YR
      EXPRESSION OF INTERLEUKIN-1-BETA AND INTERLEUKIN-1-BETA CONVERTING-ENZYME BY INTESTINAL MACROPHAGES IN HEALTH AND INFLAMMATORY BOWEL-DISEASE

      Gut
    79. STACK WA; HAWKEY GM; ATHERTON JC; PEARSON G; EVERITT S; FIELDING K; LOGAN RFA; HAWKEY CJ
      GOOD AND BAD HELICOBACTER - CAGA STATUS AND NSAID USE AS INDEPENDENT RISK-FACTORS FOR PEPTIC-ULCER BLEEDING

      Gut
    80. HAWKEY CJ; SWANNELL AJ; NAESDAL J; WALAN A; YEOMANS ND
      NSAIDS - MEN ARE FROM MARS, WOMEN ARE FROM VENUS - SEX-RELATED DIFFERENCES IN ULCER DISEASE EXPRESSION AND THE INFLUENCE OF HELICOBACTER-PYLORI

      Gut
    81. LETLEY DP; LASTOVICA A; LOUW JA; HAWKEY CJ; ATHERTON JC
      DIVERSITY IN VACA OF HELICOBACTER-PYLORI STRAINS FROM SOUTH-AFRICA - LACK OF THE PATHOGENIC VACA S1A GENOTYPE AND DISCOVERY OF A VACA S2 M1ALLELE/

      Gut
    82. DONNELLY MT; STACK WA; COURTAULD EM; GARLICK N; DELSOLDATO P; HAWKEY CJ
      NITRIC-OXIDE DONATING FLURBIPROFEN (HCT-1026) CAUSES LESS ENDOSCOPIC DAMAGE IN HEALTHY-VOLUNTEERS THAN FLURBIPROFEN

      Gut
    83. HAWKEY CJ
      REDUCED PERFORATIONS, ULCERS, BLEEDS AND HOSPITALIZATION FOR GI ADVERSE EVENTS WITH MELOXICAM COMPARED TO DICLOFENAC AND PIROXICAM

      Gut
    84. DONNELLY MT; STACK WA; RICHARDSON P; COURTAULD EM; LANGE R; HAWKEY CJ
      DOSE-RESPONSE STUDY COMPARING ENDOSCOPIC DAMAGE OF 3 DIFFERENT DOSES OF KETOPROFEN WITH ONE DOSE OF IBUPROFEN

      Gut
    85. DONNELLY MT; STACK WA; RICHARDSON P; COURTAULD EM; ALLAN LM; KIFF PS; HAWKEY CJ
      MICROENCAPSULATED ASPIRIN, ASACARD, REDUCES ENDOSCOPIC DAMAGE IN HEALTHY-VOLUNTEERS COMPARED TO CONVENTIONAL ENCAPSULATED ASPIRIN

      Gut
    86. SEAGER JM; PO ALW; LOGAN RFA; HAWKEY CJ
      RATIONAL PRESCRIBING OF PROPHYLAXIS IN PATIENTS TAKING NSAIDS

      Gut
    87. HAWKEY GM; STACK WA; COLE AT; LONG RG; LOGAN RFA; HAWKEY CJ
      BLOOD IN THE STOMACH AS A SURROGATE FOR CLINICAL END-POINTS IN GI BLEEDING TRIALS

      Gut
    88. LETLEY DP; TWELLS RJ; DOVE BK; HAWKEY CJ; COVER TL; ATHERTON JC
      DETERMINANTS OF HELICOBACTER-PYLORI VACUOLATING CYTOTOXIN PRODUCTION ANALYZED BY CONSTRUCTION OF VACA HYBRIDS AND BY SITE-DIRECTION MUTAGENESIS

      Gut
    89. JACKSON LM; WU K; MAHIDA YR; JENKINS D; DONNELLY MT; HAWKEY CJ
      COX-1 EXPRESSION IN HUMAN GASTRIC-MUCOSA INFECTED WITH HELICOBACTER-PYLORI - CONSTITUTIVE OR INDUCED

      Gut
    90. GARLICK NM; ROBINS RA; GALVIN A; HAWKEY CJ; COLE AT
      HUMAN FECAL DIALYSATE BIOACTIVITY - INACTIVATION BY CACO-2 EPITHELIALMONOLAYERS AND BY CYCLOSPORINE-H

      Gut
    91. DELBUONO R; BELTINGER J; JACKSON L; HAWKEY CJ; MAHIDA YR
      PRIMARY ADULT HUMAN COLONIC SUBEPITHELIAL MYOFIBROBLASTS INDUCE MORPHOLOGICAL AND CYTOLOGICAL DIFFERENTIATION IN T84 COLONIC EPITHELIAL-CELLS

      Gut
    92. WU KC; JACKSON L; GALVIN A; GRAY T; HAWKEY CJ; MAHIDA YR
      CHARACTERIZATION OF LAMMA PROPRIA LYMPHOCYTES, MACROPHAGES AND MYOFIBROBLASTS MIGRATING OUT OF HUMAN GASTRIC-MUCOSA DENUDED OF EPITHELIAL-CELLS

      Gut
    93. DONNELLY MT; STACK WA; RICHARDSON P; COURTAULD EM; LANGE R; HAWKEY CJ
      DOSE-RESPONSE STUDY COMPARING ENDOSCOPIC DAMAGE OF 3 DIFFERENT DOSES OF KETOPROFEN WITH ONE DOSE OF IBUPROFEN

      Gastroenterology
    94. DONNELLY MT; STACK WA; RICHARDSON P; COURTAULD EM; ALLAN LM; KIFF PS; HAWKEY CJ
      MICROENCAPSULATED ASPIRIN, ASACARD, REDUCES ENDOSCOPIC DAMAGE IN HEALTHY-VOLUNTEERS COMPARED TO CONVENTIONAL ENCAPSULATED ASPIRIN

      Gastroenterology
    95. DONNELLY MT; STACK WA; COURTAULD EM; GARLICK N; DELSOLDATO P; HAWKEY CJ
      NITRIC-OXIDE DONATING FLURBIPROFEN (HCT-1026) CAUSES LESS ENDOSCOPIC DAMAGE IN HEALTHY-VOLUNTEERS THAN FLURBIPROFEN

      Gastroenterology
    96. HAWKEY CJ; TULLASSAY Z; SZCEPANSKI L; VANRENSBURG CJ; FILIPOWICZSOSNOWSKA A; LANAS A; PEACOCK RA; GILLON KRW
      FAILURE OF HELICOBACTER-PYLORI ERADICATION TO INFLUENCE SITE-SPECIFICRELAPSE IN HIGH-RISK NSAID USERS - RESULTS OF A LARGE 6 MONTH DOUBLE-BLIND RANDOMIZED CONTROLLED CLINICAL-TRIAL

      Gastroenterology
    97. HAWKEY CJ; SWANNELL AJ; NAESDAL J; WALAN A; YEOMANS ND
      INFLUENCE OF SEX AND HELICOBACTER-PYLORI ON TYPE AND LOCATION OF LESIONS IN NSAID-USERS

      Gastroenterology
    98. HAWKEY CJ
      REDUCED PERFORATIONS, ULCERS, BLEEDS AND HOSPITALIZATION FOR GI ADVERSE EVENTS WITH MELOXICAM COMPARED TO DICLOFENAC AND PIROXICAM

      Gastroenterology
    99. HAWKEY GM; STACK WA; COLE AT; LONG RG; LOGAN RFA; HAWKEY CJ
      BLOOD IN THE STOMACH AS A SURROGATE FOR CLINICAL END-POINTS IN GI BLEEDING TRIALS

      Gastroenterology
    100. JACKSON LM; WU K; MAHIDA YR; JENKINS D; DONNELLY MT; HAWKEY CJ
      COX-1 EXPRESSION IN HUMAN GASTRIC-MUCOSA INFECTED WITH HELICOBACTER-PYLORI - CONSTITUTIVE OR INDUCED

      Gastroenterology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/02/20 alle ore 23:06:50